An observational study in Liver Transplantation and Auxiliary Liver Transplantation, sponsored by Zhi-Jun Zhu. Not yet recruiting. Per ClinicalTrials.gov, last updated 2025-12-10.
Sponsored by Zhi-Jun Zhu · Observational
The objective of this observational study is to systematically compare the efficacy and patient prognosis between auxiliary liver transplantation and living donor liver transplantation, and to explore the postoperative recovery, survival rate, rejection, postoperative complications, and long-term prognosis of patients undergoing auxiliary liver transplantation.
Zhi-Jun Zhu is the lead sponsor of 4 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who were treated at the Liver Transplantation Center of Beijing Friendship Hospital, Capital Medical University between December 2025 and December 2028, and who underwent either auxiliary liver transplantation (study group) or conventional liver transplantation (control group).
Exclusion Criteria:
Patients who underwent auxiliary liver transplantation at our center during the study period
Patients who underwent traditional orthotopic living donor liver transplantation at our center during the study period.
Overall survival
Time frame: Within one year after liver transplantation
Complications
Rejection, vascular, biliary and other related complications
Time frame: Within one year after liver transplantation
changes in peripheral blood lymphocytes
Peripheral blood lymphocytes during the early post-transplant period were compared between the auxiliary and living donor liver transplantation groups to identify differences.
Time frame: within 3 months after liver transplantation
No study locations are listed for this record.
Plan to share: No
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zhi-Jun Zhu